The New York Mets have officially secured the services of 36-year-old journeyman Robert Stock for the 2027 season, signing him to a one-year Major League contract. The move follows a turbulent 2026 campaign where Stock initially signed on a minor league deal but missed significant time due to surgery for arterial thoracic outlet syndrome. After completing a series of rehab starts, the Mets selected his contract on August 2, deploying him in a hybrid capacity as both a reliever and a starter for the remainder of the year. This contract signals the organization’s intent to keep Stock in the fold, though his specific role remains the central question for the upcoming offseason.
Key Match Highlights & Tactical Analysis
Statistically, Stock’s 2026 performance was underwhelming, posting a 1-3 record with a 5.93 ERA across eight appearances. The right-hander allowed 20 earned runs over 30 1/3 innings, with seven of those outings coming as a starter and one as a reliever. While his experience offers depth, these numbers indicate he is not currently operating at a level that demands a primary rotation spot. The Mets’ pitching staff is heavily invested in young talent, making it unlikely that Stock will displace established or emerging starters in the near term.
Looking ahead to 2027, Stock faces stiff competition for a starting spot, particularly from rising arms like Nolan McLean, Christian Scott, and Zac Thornton. The Mets are unlikely to slot Stock into the core rotation given his recent struggles and the depth of their young pitching pipeline. Instead, he is poised to serve as a high-leverage reliever or a spot starter, providing veteran leadership and innings depth. For Stock, the challenge will be proving he can maintain effectiveness in a reduced workload to justify his Major League roster spot in a crowded market.
Source: Yahoo Sports
